Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis.
Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, Wolinsky JS, Ziemssen T. Berger JR, et al. Among authors: miravalle a. Ann Neurol. 2010 Sep;68(3):409-11. doi: 10.1002/ana.22083. Ann Neurol. 2010. PMID: 20818795 No abstract available.
Emerging therapies for treatment of multiple sclerosis.
Corboy JR, Miravalle AA. Corboy JR, et al. Among authors: miravalle aa. J Inflamm Res. 2010;3:53-9. doi: 10.2147/jir.s6558. Epub 2010 Jul 23. J Inflamm Res. 2010. PMID: 22096357 Free PMC article.
Neurologic complications of vaccinations.
Miravalle AA, Schreiner T. Miravalle AA, et al. Handb Clin Neurol. 2014;121:1549-57. doi: 10.1016/B978-0-7020-4088-7.00103-6. Handb Clin Neurol. 2014. PMID: 24365435 Review.
32 results